Abstract
Heart disease is associated with the accumulation of resident cardiac fibroblasts that secrete extracellular matrix (ECM) and drive the development of pathological fibrosis and heart failure. However, the mechanisms underlying fibroblast proliferation and activation remain poorly defined. To address this gap in understanding we have utilized transcriptional profiling to characterize the cardiac fibroblast phenotype in health and disease. Cardiac fibroblasts exhibit dynamic changes in genes encoding cell cycle regulators and ECM proteins. Here, we report that the cardiac fibroblast cell cycle is in part controlled by Sprr2b, a small proline‐rich protein that is induced in heart disease and extinguished during exercise. Sprr2b is a novel regulatory component of the USP7/MDM2‐containing ubiquitination complex. Sprr2b stimulates MDM2‐dependent p53 degradation, thus facilitating the proliferation of pathological cardiac fibroblasts. These findings establish a paradigm of transcriptional regulation that governs cardiac fibroblast phenotypic plasticity and the development of pathological cardiac fibrosis.Support or Funding InformationNIH / NHLBI R01‐HL133761 and R01‐HL120919This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
